Qube Research & Technologies LTD Viracta Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$1.03 - $1.58 $2 - $3	2 New	2 $0
Q3 2022 Nov 14, 2022	SELL	$3.32 - $5.69 $12,164 - $20,848	-3,664 Reduced 11.85%	27,252 $116,000
Q2 2022 Aug 15, 2022	BUY	$1.87 - $5.0 $57,812 - $154,580	30,916 New	30,916 $120,000
Q2 2021 Aug 13, 2021	SELL	$7.55 - $12.95 $77,961 - $133,721	-10,326 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$7.58 - $18.67 $78,271 - $192,786	10,326 New	10,326 $96,000

3.66M

1.8K

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $1.13M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.